Literature DB >> 7129204

Biliary lipid secretion in chronic cholestatic liver disease.

Y A Kesäniemi, M P Salaspuro, M Vuoristo, T A Miettinen.   

Abstract

Biliary lipid secretion rates, faecal steroids, and serum lipids were studied in patients with chronic cholestatic liver disease mainly primary biliary cirrhosis. The biliary secretion of cholesterol, bile acids, and phospholipids was markedly decreased as compared with those in the control group and in general correlated negatively with the serum cholesterol and triglyceride values. The molar percentage of cholesterol was increased in the hepatic bile. This suggests that, in cholestatic liver disease, in contrast with the normal state, the hapatic bile may be supersaturated postprandially. Faecal bile acids and neutral sterols of cholesterol origin were decreased proportionately to the corresponding biliary lipid secretion rates. In fact, both biliary and faecal steroid outputs were only about a half or less than those in the controls, indicating that the fractional absorption was not changed but absolute absorption and faecal steroid excretion were low in patients with chronic cholestatic liver disease. Thus, despite low cholesterol and bile acid absorption, cholesterol and bile acid synthesis is low. A negative correlation between faecal steroids and serum cholesterol suggests that the high serum cholesterol level contributed to regulation of cholesterol synthesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7129204      PMCID: PMC1419800          DOI: 10.1136/gut.23.11.931

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.

Authors:  S M GRUNDY; E H AHRENS; T A MIETTINEN
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

3.  A simplified method for the determination of chromic oxide (Cr2 O3) when used as an index substance.

Authors:  D W BOLIN; R P KING; E W KLOSTERMAN
Journal:  Science       Date:  1952-12-05       Impact factor: 47.728

4.  A physiological method for estimation of hepatic secretion of biliary lipids in man.

Authors:  S M Grundy; A L Metzger
Journal:  Gastroenterology       Date:  1972-06       Impact factor: 22.682

5.  Demonstration of an intracellular copper-binding protein by orcein staining in long-standing cholestatic liver diseases.

Authors:  M Salaspuro; P Sipponen
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

6.  Usefulness of chromic oxide as an internal standard for balance studies in formula-fed patients and for assessment of colonic function.

Authors:  J Davignon; W J Simmonds; E H Ahrens
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

7.  Pigment vs cholesterol cholelithiasis: clinical and epidemiological aspects.

Authors:  B W Trotman; R D Soloway
Journal:  Am J Dig Dis       Date:  1975-08

8.  Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes.

Authors:  Y A Kesäniemi; T A Miettinen; M P Salaspuro
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

9.  Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease.

Authors:  H O WHEELER; J I MELTZER; S E BRADLEY
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

10.  Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease.

Authors:  T A Miettinen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

View more
  3 in total

Review 1.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

2.  Biliary lipid compositions in cholestatic diseases of infancy.

Authors:  Y Tazawa; M Yamada; M Nakagawa; T Konno; K Tada
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

3.  Biliary lipid metabolism in children with chronic intrahepatic cholestasis.

Authors:  M Becker; K von Bergmann; H W Rotthauwe; O Leiss
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.